קם-רהו די I.M

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

ANTI-D IMMUNOGLOBULINS

Tilgjengelig fra:

KAMADA LTD, ISRAEL

ATC-kode:

J06BB01

Legemiddelform:

תמיסה להזרקה

Sammensetning:

ANTI-D IMMUNOGLOBULINS 150 MCG/ML

Administreringsrute:

תוך-שרירי

Resept typen:

מרשם נדרש

Produsert av:

KAMADA LTD, ISRAEL

Terapeutisk gruppe:

ANTI-D (RH) IMMUNOGLOBULIN

Terapeutisk område:

ANTI-D (RH) IMMUNOGLOBULIN

Indikasjoner:

Pregnancy/other obstetric conditions, Suppression of Rh immunization in non-sensitized Rh0 (D) negative women delivering an Rh0 positive baby or when the baby's Rh type is unknown. Suppression of Rh immunization after spontaneous or induced abortions threatened abortion associated with maternal bleeding amniocentesis chorionic villus sampling ruptured tubal pregnancy and significant abdominal trauma. Kam Rh0 -D IM should be given within 72 hours of the event. It may be given even after up to one month although efficacy may be somewhat reduced.Transfusion: Suppression of Rh isoimmunization in Rh0 (D) antigen-negative patients transfused with Rh0 (D) antigen-positive RBCs of blood components containing Rh0 (D) antigen-positive RBCs . Initate treatment within 72 hours of exposure.

Autorisasjon dato:

2022-01-31